{rfName}
HP

APC

4 978,00 Dollars

License and Use

Icono OpenAccess

Altmetrics

Impact on the Sustainable Development Goals (SDGs)

Analysis of institutional authors

Bosch Jose, FcojavierAuthorGil Martin, MartaAuthorCastellsague, XCorresponding AuthorSzafarowski T.AuthorTous, SAuthorCadena, EAuthor

Share

March 18, 2016
Publications
>
Article

HPV Involvement in Head and Neck Cancers: Comprehensive Assessment of Biomarkers in 3680 Patients

Publicated to: Jnci-Journal Of The National Cancer Institute. 108 (6): djv403-NA - 2016-06-01 108(6), DOI: 10.1093/jnci/djv403

Authors: Castellsagué, X; Alemany, L; Quer, M; Halec, G; Quirós, B; Tous, S; Clavero, O; Alòs, L; Biegner, T; Szafarowski, T; Alejo, M; Holzinger, D; Cadena, E; Claros, E; Hall, G; Laco, J; Poljak, M; Benevolo, M; Kasamatsu, E; Mehanna, H; Ndiaye, C; Guimerà, N; Lloveras, B; León, X; Ruiz-Cabezas, JC; Alvarado-Cabrero, I; Kang, CS; Oh, JK; Garcia-Rojo, M; Iljazovic, E; Ajayi, OF; Duarte, F; Nessa, A; Tinoco, L; Duran-Padilla, MA; Pirog, EC; Viarheichyk, H; Morales, H; Costes, V; Félix, A; Germar, MJV; Mena, M; Ruacan, A; Jain, A; Mehrotra, R; Goodman, MT; Lombardi, LE; Ferrera, A; Malami, S; Albanesi, EI; Dabed, P; Molina, C; López-Revilla, R; Mandys, V; González, ME; Velasco, J; Bravo, IG; Quint, W; Pawlita, M; Muñoz, N; de Sanjosé, S; Bosch, FX

Affiliations

Bangabandhu Sheikh Mujib Med Univ, Dept Obstet & Gynecol, Dhaka, Bangladesh - Author
Bayero Univ, Kano, Nigeria - Author
Canc Prevent & Relief Soc, Raipur, Madhya Pradesh, India - Author
Catholic Univ Korea, Yeouido St Marys Hosp, Seoul, South Korea - Author
Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA - Author
Cent Univ Venezuela, Caracas, Venezuela - Author
Charles Univ Prague, Fac Med 3, Prague, Czech Republic - Author
Charles Univ Prague, Fac Med, Fingerland Dept Pathol, Hradec Kralove, Czech Republic - Author
CHRU Gui De Chauliac, Montpellier, France - Author
CIBER Epidemiol & Salud Publ CIBERESP, Madrid, Spain - Author
Ctr Canc Emma Romero Callejas, Tegucigalpa, Honduras - Author
DDL Diagnost Lab, Rijswijk, Netherlands - Author
Fac Hosp Kings Vineyards, Prague, Czech Republic - Author
German Canc Res Ctr, Heidelberg, Germany - Author
Gomel State Med Univ, Gomel, BELARUS - Author
Hacettepe Univ, Sch Med, Ankara, Turkey - Author
Hosp Gen Hosp, Barcelona, Spain - Author
Hosp Gen Jerez de la Frontera, Cadiz, Spain - Author
Hosp Gen Mexico City, Dept Pathol, Mexico City, DF, Mexico - Author
Hosp Gen San Juan de Dios, Ctr Invest Epidemiol Salud Sexual Reprod CIESAR, Guatemala City, Guatemala - Author
Hosp Oncol SOLCA, Quito, Ecuador - Author
Hosp San Agustin, Asturias, Spain - Author
Hosp Santa Creu & Sant Pau, Barcelona, Spain - Author
Hosp SOLCA, Lab Clin & Mol, Guayaquil, Ecuador - Author
IDIBELL, Catalan Inst Oncol ICO, Canc Epidemiol Res Program, Lhospitalet De Llobregat, Catalonia, Spain - Author
IMAT Oncomed, Monteria, Colombia - Author
IMSS Mexico, Ctr Med Nacl Siglo 21, Hosp Oncol, Mexico City, DF, Mexico - Author
Insituto Oncol Oriente Boliviano, Lab Privado Patol Oncos, Santa Cruz, Bolivia - Author
Inst Cancerol Dr Bernardo del Valle S, Guatemala City, Guatemala - Author
Inst Cytol & Prevent Oncol ICMR, Noida, Uttar Pradesh, India - Author
Inst Nacl Cancerol, Bogota, Colombia - Author
Inst Portugues Oncol Francisco Gentil, Lisbon, Portugal - Author
Inst Potosino Invest Cient & Tecnol IPICYT, San Luis Potosi, Mexico - Author
Koc Univ, Sch Med, Istanbul, Turkey - Author
Manchester Royal Infirm, Oxford Rd, Manchester M13 9WL, Lancs, England - Author
Med Univ Warsaw, Czerniakowski Hosp, Fac Med & Dent, Dept Otorhinolaryngol, Warsaw, Poland - Author
Minist Salud Prov Buenos Aires, Buenos Aires, DF, Argentina - Author
MLN Med Coll, Allahabad, Uttar Pradesh, India - Author
Natl Canc Ctr, Grad Sch Canc Sci & Policy, Goyang, South Korea - Author
Natl Canc Ctr, Natl Canc Control Inst, Goyang, South Korea - Author
New York Hosp, Cornell Med Ctr, New York, NY 10021 USA - Author
Regina Elena Inst Canc Res, Rome, Italy - Author
Univ Barcelona, Hosp Clin, E-08007 Barcelona, Spain - Author
Univ Birmingham, Inst Head & Neck Studies & Educ, Birmingham, W Midlands, England - Author
Univ Chile, Ctr Oncol Prevent, Santiago, Chile - Author
Univ Clin Ctr, Dept Pathol, Tuzla, Bosnia & Herceg - Author
Univ Hawaii, Canc Res Ctr, Honolulu, HI 96822 USA - Author
Univ Hosp Tuebingen, Dept Pathol, Tubingen, Germany - Author
Univ Hosp, Hradec Kralove, Czech Republic - Author
Univ Lagos, Coll Med, Dept Oral Pathol, Lagos, Nigeria - Author
Univ Ljubljana, Fac Med, Inst Microbiol & Immunol, Ljubljana, Slovenia - Author
Univ Montreal, Dept Social & Prevent Med, Montreal, PQ, Canada - Author
Univ Nacl Asuncion, Inst Invest Ciencias Salud, Asuncion, Paraguay - Author
Univ Nacl Autonoma Honduras, Escuela Microbiol, Tegucigalpa, Honduras - Author
Univ Nacl Colombia, Bogota, Colombia - Author
Univ Philippines, Coll Med, Manila, Philippines - Author
Univ Pompeu Fabra, Hosp del Mar IMIM, Dept Pathol, Barcelona, Spain - Author
See more

Abstract

We conducted a large international study to estimate fractions of head and neck cancers (HNCs) attributable to human papillomavirus (HPV-AFs) using six HPV-related biomarkers of viral detection, transcription, and cellular transformation.Formalin-fixed, paraffin-embedded cancer tissues of the oral cavity (OC), pharynx, and larynx were collected from pathology archives in 29 countries. All samples were subject to histopathological evaluation, DNA quality control, and HPV-DNA detection. Samples containing HPV-DNA were further subject to HPV E6*I mRNA detection and to p16(INK4a), pRb, p53, and Cyclin D1 immunohistochemistry. Final estimates of HPV-AFs were based on HPV-DNA, HPV E6*I mRNA, and/or p16(INK4a) results.A total of 3680 samples yielded valid results: 1374 pharyngeal, 1264 OC, and 1042 laryngeal cancers. HPV-AF estimates based on positivity for HPV-DNA, and for either HPV E6*I mRNA or p16(INK4a), were 22.4%, 4.4%, and 3.5% for cancers of the oropharynx, OC, and larynx, respectively, and 18.5%, 3.0%, and 1.5% when requiring simultaneous positivity for all three markers. HPV16 was largely the most common type. Estimates of HPV-AF in the oropharynx were highest in South America, Central and Eastern Europe, and Northern Europe, and lowest in Southern Europe. Women showed higher HPV-AFs than men for cancers of the oropharynx in Europe and for the larynx in Central-South America.HPV contribution to HNCs is substantial but highly heterogeneous by cancer site, region, and sex. This study, the largest exploring HPV attribution in HNCs, confirms the important role of HPVs in oropharyngeal cancer and drastically downplays the previously reported involvement of HPVs in the other HNCs.© The Author 2016. Published by Oxford University Press. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.

Keywords

Good health and well-being

Quality index

Bibliometric impact. Analysis of the contribution and dissemination channel

The work has been published in the journal Jnci-Journal Of The National Cancer Institute due to its progression and the good impact it has achieved in recent years, according to the agency WoS (JCR), it has become a reference in its field. In the year of publication of the work, 2016, it was in position 9/217, thus managing to position itself as a Q1 (Primer Cuartil), in the category Oncology.

This publication has been distinguished as a “Highly Cited Paper” by the agencies WoS (ESI, Clarivate) and ESI (Clarivate), meaning that it ranks within the top 1% of the most cited articles in its thematic field during the year of its publication. In terms of the observed impact of the contribution, this work is considered one of the most influential worldwide, as it is recognized as highly cited. (source consulted: ESI Nov 13, 2025)

And this is evidenced by the extremely high normalized impacts through some of the main indicators of this type, which, although dynamic over time and dependent on the set of average global citations at the time of calculation, already indicate that they are well above the average in different agencies:

  • Normalization of citations relative to the expected citation rate (ESI) by the Clarivate agency: 15.18 (source consulted: ESI Nov 13, 2025)
  • Weighted Average of Normalized Impact by the Scopus agency: 16.47 (source consulted: FECYT Mar 2025)

Specifically, and according to different indexing agencies, this work has accumulated citations as of 2025-12-15, the following number of citations:

  • WoS: 530
  • Scopus: 573
  • Europe PMC: 337
  • Google Scholar: 290
  • Open Alex: 658

Impact and social visibility

From the perspective of influence or social adoption, and based on metrics associated with mentions and interactions provided by agencies specializing in calculating the so-called "Alternative or Social Metrics," we can highlight as of 2025-12-15:

  • The use, from an academic perspective evidenced by the Altmetric agency indicator referring to aggregations made by the personal bibliographic manager Mendeley, gives us a total of: 522.
  • The use of this contribution in bookmarks, code forks, additions to favorite lists for recurrent reading, as well as general views, indicates that someone is using the publication as a basis for their current work. This may be a notable indicator of future more formal and academic citations. This claim is supported by the result of the "Capture" indicator, which yields a total of: 524 (PlumX).

With a more dissemination-oriented intent and targeting more general audiences, we can observe other more global scores such as:

  • The Total Score from Altmetric: 87.
  • The number of mentions on the social network Facebook: 1 (Altmetric).
  • The number of mentions on the social network X (formerly Twitter): 31 (Altmetric).
  • The number of mentions in news outlets: 6 (Altmetric).

It is essential to present evidence supporting full alignment with institutional principles and guidelines on Open Science and the Conservation and Dissemination of Intellectual Heritage. A clear example of this is:

  • The work has been submitted to a journal whose editorial policy allows open Open Access publication.
Continuing with the social impact of the work, it is important to emphasize that, due to its content, it can be assigned to the area of interest of ODS 3 - Good Health and Well-Being, with a probability of 45% according to the mBERT algorithm developed by Aurora University.

Leadership analysis of institutional authors

This work has been carried out with international collaboration, specifically with researchers from: Argentina; Bangladesh; Bolivia; Bosnia Herzegovina; Byelorussia; Canada; Chile; Colombia; Czech Republic; Ecuador; France; Germany; Guatemala; Honduras; India; Italy; Mexico; Netherlands; Niger; Nigeria; Paraguay; Philippines; Poland; Portugal; Republic of Korea; Slovenia; Turkey; United Kingdom; United States of America; Venezuela.

There is a significant leadership presence as some of the institution’s authors appear as the first or last signer, detailed as follows: First Author (Castellsague Pique, Xavier) and Last Author (Kasamatsu, E).

the author responsible for correspondence tasks has been Castellsague Pique, Xavier.